Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002027680-25-000006
Filing Date
2025-12-19
Accepted
2025-12-19 15:06:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5159
  Complete submission text file 0002027680-25-000006.txt   6701
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Subject) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86699 | Film No.: 251587126
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)

Mailing Address 16 APPLETON ST BOSTON MA 02116
Business Address
Morrison Todd Hale (Filed by) CIK: 0002027680 (see all company filings)

Type: SCHEDULE 13G/A